Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Mayo Clin Proc. 2019 Aug 9;94(9):1825–1831. doi: 10.1016/j.mayocp.2019.04.010

Table 1.

Demographic characteristics of the patients included in the study with clinical diagnosis of synucleinopathy

Men Age at diagnosis Age at Death
Diagnosis Total N N (%) Median (IQR) Number
Died*
Median (IQR)
All 433 264 (61.0%) 76.1 (68.8, 82.3) 290 84.5 (79.3, 89.8)
PD 301 181 (60.1%) 74.8 (66.9, 81.7) 168 86.1 (79.6, 90.5)
PDD 52 26 (50.0%) 82.1 (75.9, 87.6) 50 84.5 (79.7, 90.9)
DLB 68 48 (70.6%) 76.9 (72.4, 80.7) 60 83.1 (78.8, 87.0)
MSA-p 12 9 (75.0%) 72.9 (64.3, 77.4) 12 80.8 (67.1, 84.9)

PD = Parkinson’s disease; PDD = Parkinson’s disease Dementia; DLB = Dementia with Lewy Bodies; MSA-p= Multiple Systems Atrophy with Parkinsonism

*

Died by end of the study timeframe (June 30, 2015)